Skip to content
  • Facebook
  • Instagram
  • TikTok
  • Mastodon
  • YouTube
  • X
  • Twitch

Scientific Inquirer

  • Everyday Science.
  • Left Brain/Right Brain.
  • Sports.
  • Features.
  • About.
  • Contact.

clinical trials

  • Cellular therapy improves signs and symptoms of Duchenne muscular dystrophy.
    March 18, 2022

    Cellular therapy improves signs and symptoms of Duchenne muscular dystrophy.

    bricemarsters
  • Almost all kids have tobacco on their hands, even in non-smoking homes.
    February 11, 2022

    Almost all kids have tobacco on their hands, even in non-smoking homes.

    bricemarsters
  • People’s long-term pain after knee surgery is reduced, new treatment has shown.
    February 1, 2022

    People’s long-term pain after knee surgery is reduced, new treatment has shown.

    bricemarsters
  • Hyperimmune intravenous immunoglobulin does not improve outcomes for adults hospitalized with COVID-19
    January 31, 2022

    Hyperimmune intravenous immunoglobulin does not improve outcomes for adults hospitalized with COVID-19

    bricemarsters
  • Clinical trial reveals that omega-3 fish oil supplements do not help prevent depression.
    December 24, 2021

    Clinical trial reveals that omega-3 fish oil supplements do not help prevent depression.

    bricemarsters
  • Delaying second dose of mRNA COVID-19 vaccine produces stronger immune response.
    December 7, 2021

    Delaying second dose of mRNA COVID-19 vaccine produces stronger immune response.

    bricemarsters
  • Practice-changing trial results for advanced melanoma skin cancer.
    November 19, 2021

    Practice-changing trial results for advanced melanoma skin cancer.

    bricemarsters
  • Safety concerns raised for neuroblastoma candidate drug.
    November 13, 2021

    Safety concerns raised for neuroblastoma candidate drug.

    bricemarsters
  • Racial representation in clinical trials is a big problem
    September 21, 2020

    Racial representation in clinical trials is a big problem

    scientificinquirer
  • Ebola vaccine candidates pass another key hurdle in trials
    October 18, 2017

    Ebola vaccine candidates pass another key hurdle in trials

    scientificinquirer
Previous Page
1 … 3 4 5 6
Next Page

Categories

Asia.

North America.

Europe.

Africa.

South America.

Australia.

Science For All, Not Just The Few.

Subscribe to our newsletters. We’ll keep you in the loop.

  • Facebook
  • Instagram
  • TikTok
  • Mastodon
  • YouTube
  • X
  • Twitch
  • Everyday Science.
  • Left Brain/Right Brain.
  • Sports.
  • Features.
  • About.
  • Contact.

Designed with WordPress

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}

Loading Comments...